SBIR Reauthorization 2026: What Changed in S. 3971 and What Founders Need to Do Now

The SBIR and STTR programs were reauthorized on April 13, 2026 through the Small Business Innovation and Economic Security Act (S. 3971), signed by President Trump after a six-month lapse in program authority. The law extends both programs through September 30, 2031 — a five-year window that eliminates the recurring three-year reauthorization crises — and adds a new Phase II "Strategic Breakthrough" award with a $30 million ceiling, alongside expanded foreign risk screening and administrative updates.

For any US small business currently in an SBIR pipeline, this ends the paperwork limbo that halted new awards between October 2025 and April 2026. For founders considering their first application, the calendar is now stable through 2031 for the first time in a decade.

Why was there a six-month lapse?

The prior authorization expired on September 30, 2025. From October 2025 through April 12, 2026, federal agencies could not issue new SBIR or STTR awards. Applications submitted during the lapse sat in queues; contracts pending signature were paused; and Phase II decisions that would ordinarily process in October-February slipped into the second quarter of 2026.

The legislation cleared the U.S. Senate on March 3, 2026 and passed the House on March 17, 2026 (IEDC summary). President Trump signed it on April 13. Awards resumed within days at most agencies, though NIH, DoD, and NSF each announced slightly different re-start timelines.

What is the new Strategic Breakthrough Phase II?

The most substantive addition in S. 3971 is a new Phase II funding vehicle called the Strategic Breakthrough award, with a ceiling of $30 million. This is roughly a 20× jump from the standard Phase II ceiling of ~$1.5M–$2M and is designed for projects with "significant national security, economic security, or public health implications" (per CSIS analysis).

Not every Phase I awardee will be eligible. Strategic Breakthrough awards require:

• Demonstrated commercialization traction in Phase I or a prior Phase II
• Clear articulation of the "strategic" impact (national security, critical technology, etc.)
• Agency discretion — each participating agency will define its own selection criteria

Expect the first Strategic Breakthrough solicitations in mid-to-late 2026 as agencies publish implementing guidance.

What foreign risk screening changes were added?

S. 3971 strengthens the foreign-influence review already introduced in the 2022 reauthorization. Key changes:

• Broader disclosure requirements for all key personnel with foreign affiliations, including educational and professional relationships that were previously flagged only above certain thresholds.
• Ongoing certification — applicants and awardees must certify foreign affiliations at multiple points, not just at initial application.
• Explicit prohibition on Chinese, Russian, Iranian, and North Korean government-affiliated funding running through the same PI on any SBIR-funded project.

For most founders, this means the SF-424 form and biosketches will require more detail. Applications should confirm they meet the current version of the foreign risk certification, which will be updated on Grants.gov and agency portals throughout Q3 2026.

How does this affect current SBIR Phase I applicants?

If you submitted a Phase I application between October 2025 and April 2026, the review clock effectively paused. Most agencies restarted reviews within 4-6 weeks of the April 13 signing. Expect notification of decisions on a rolling basis through summer 2026, with some Q2 2025 applicants receiving decisions well into Q3 2026.

If you have a pending Phase II decision, the same applies: awards are being issued but at a compressed pace. Check the agency's SBIR portal (SBIR.gov, NIH RePORTER, DoD DSIP) for the specific status of your submission.

If you're considering a first application in 2026, the calendar is more predictable than it has been in three years — solicitations resumed on their normal cadence, and the five-year authorization window (through 2031) removes the "will the program still exist?" question that has haunted SBIR planning since 2022.

Which agencies are affected?

All 11 participating SBIR agencies:

| Agency | Program size (FY 2024, most recent published) | |---|---| | Department of Defense | ~$1.8B | | National Institutes of Health | ~$1.2B | | Department of Energy | ~$300M | | National Science Foundation | ~$220M | | NASA | ~$200M | | USDA | ~$50M | | DHS | ~$45M | | Department of Education | ~$25M | | Department of Transportation | ~$20M | | NIST | ~$18M | | EPA | ~$10M |

Program sizes may shift under the FY 2026-2027 budget cycle, particularly as broader SBA reforms redirect entrepreneurship funding (Small Business Majority summary). SBIR is a set-aside percentage of each agency's extramural R&D budget, so agency-level budget changes flow into program size.

What to do now (60-day founder checklist)

• Confirm your SAM.gov entity registration is current. Any expired SAM registration blocks all federal grant applications, including SBIR. Renewal takes 5-10 business days.
• Review the foreign risk certification requirements on your target agency's SBIR portal. Update biosketches and personnel disclosures as needed.
• Track solicitation calendars — DoD (DSIP), NIH (SBIR/STTR portal), NSF (America's Seed Fund) each publish rolling and cycle-based deadlines. The next major cycles land Q4 2026.
• If you're at Phase II decision point, verify with your program officer whether your review completed during the lapse or was queued for the April restart.

Sources

• Congress: Small Business Innovation and Economic Security Act of 2026 (S. 3971)
• IEDC: Congress Reauthorizes SBIR and STTR Programs
• CSIS: SBIR and STTR Reauthorization and the Future of Small Business Innovation
• Crowell: SBIR/STTR Programs Reauthorized After Six-Month Lapse

FAQ

When does SBIR expire again? September 30, 2031 — a five-year authorization window, replacing the previous three-year cycles that produced recurring 2020, 2022, and 2025 crises.

Is the Strategic Breakthrough Phase II available now? Not yet. The law authorizes it; each participating agency must publish implementing solicitations. Expect the first ones in mid-to-late 2026.

Do I need to re-register on SAM.gov because of the reauthorization? No. SAM.gov registration was not disrupted by the SBIR lapse. But confirm your registration is not expired — annual renewal is required regardless.

Does the reauthorization change Phase I dollar amounts? No — Phase I dollar ranges are unchanged (typically $50K–$300K depending on agency). The dollar changes are at Phase II, specifically the new $30M Strategic Breakthrough ceiling.

Can foreign-owned US small businesses still apply? Yes, subject to the standard 51% US citizen/permanent resident ownership requirement and the strengthened foreign risk screening in S. 3971. The core eligibility rules did not change.

How does Windfall track SBIR opportunities? Windfall syncs the full Grants.gov catalog daily plus SAM.gov Assistance Listings, which includes all SBIR solicitations from the 11 participating agencies. Match scores flag SBIR programs your business qualifies for based on industry, size, and ownership profile. See your matches free.